TRIP13 and neoplasm: Abnormal expression of TRIP13 might be related to the development and occurrence of tumours, and the overexpression of TRIP13 can promote the connection of non-homologous terminals and increase the resistance to chemotherapeutic drugs.18 However, the molecular mechanism and biological consequences of TRIP13 in GBM cells are not clear.